Benzodiazepine & Zolpidem Usage in Multiple Myeloma Patients Undergoing Transplantation
Multiple myeloma (MM) patients (pts) are older and have poorer quality of life (QOL) compared to pts with other hematologic malignancies (Nielsen et al, Eur J Haematol 2017). Autologous hematopoietic stem cell transplantation (HCT) acutely exacerbates psychosocial distress& insomnia. These symptoms are often treated with benzodiazepines and zolpidem-class drugs (B/Z Rx) that come with serious toxicities in older adults. B/Z Rx patterns in HCT recipients, particularly among MM patients who tend to be older with more co-morbidities, are unknown.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Rahul Banerjee, Lisa Dunn, Jennifer Knoche, Mimi Lo, Anand Dhruva, Shagun Arora, Sandy W. Wong, Jeffrey Wolf, Thomas G. Martin, Nina Shah Tags: 541 Source Type: research
More News: Ambien | Biology | Cancer & Oncology | Hematology | Insomnia | Myeloma | Stem Cell Therapy | Stem Cells | Toxicology | Transplants